Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: A cross-sectional analyses

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Kim, Sunmin ^a   Oh, Jisun ^a   Kim, Yu Il ^a   Ban, Hee Jung ^a   Kwon, Yong Soo ^a   Oh, In Jae ^a   Kim, Kyu Sik ^a   Kim, Young Chul ^a   Lim, Sung Chul ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

CAT; COPD; mMRC scores

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CHEST TIGHTNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSESSMENT TEST; CLINICAL FEATURE; COUGHING; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL DYSPNEA SCORE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTPATIENT; SLEEP QUALITY; SPUTUM; SYMPTOM;

AGED; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT; VITAL CAPACITY;

EID: 84878375132     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-35     Document Type: Article

References (18)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013, 187(4):347-365. 10.1164/rccm.201204-0596PP, 22878278.
2. Garcia-Aymerich J, Serra Pons I, Mannino DM, Maas AK, Miller DP, Davis KJ. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax 2011, 66(7):585-590. 10.1136/thx.2010.152876, 21515553.
3. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010, 363(12):1128-1138. 10.1056/NEJMoa0909883, 20843247.
4. Weatherall M, Marsh S, Shirtcliffe P, Williams M, Travers J, Beasley R. Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J 2009, 33(5):1025-1030. 10.1183/09031936.00116808, 19164350.
5. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010, 11:122. 2944278, 20831787.
6. Papaioannou AI, Loukides S, Gourgoulianis KI, Kostikas K. Global assessment of the COPD patient: time to look beyond FEV1?. Respir Med 2009, 103(5):650-660. 10.1016/j.rmed.2009.01.001, 19167871.
7. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999, 54(7):581-586. 10.1136/thx.54.7.581, 1745516, 10377201.
8. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009, 34(3):648-654. 10.1183/09031936.00102509, 19720809.
9. Han MK, Muellerova H, Curran-Everett D, Dransfield MT, Washko GR, Regan EA, Bowler RP, Beaty TH, Hokanson JE, Lynch DA, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013, 1(1):43-50.
10. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959, 2(5147):257-266. 10.1136/bmj.2.5147.257, 1990153, 13823475.
11. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007, 29(6):1224-1238. 10.1183/09031936.00109906, 17540785.
12. American Thoracic Society Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995, 152(3):1107-1136. American Thoracic Society.
13. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-174. 10.2307/2529310, 843571.
14. Tsiligianni IG, van der Molen T, Moraitaki D, Lopez I, Kocks JW, Karagiannis K, Siafakas N, Tzanakis N. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med 2012, 12:20. 10.1186/1471-2466-12-20, 3431277, 22607459.
15. Kelly JL, Bamsey O, Smith C, Lord VM, Shrikrishna D, Jones PW, Polkey MI, Hopkinson NS. Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respiration 2012, 84(3):193-199. 10.1159/000336549, 22441322.
16. Scichilone N, Chetta A. It's Time to Let the 'CAT' out...Patient!. Respiration 2012, 84(3):189-190. 10.1159/000337272, 22441166.
17. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler Cataluna JJ, van der Molen T, Adamek L, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011, 38(1):29-35. 10.1183/09031936.00177210, 21565915.
18. Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012, 185(11):1218-1224. 10.1164/rccm.201110-1843OC, 22281834.